Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6

Blood

Volumn 110, Issue 5, 2007, Pages 1595-1602

  Kilmon, Michelle A ^a   Wagner, Nikki J ^a   Garland, Alaina L ^a   Lin, Li ^b   Aviszus, Katja ^c   Wysocki, Lawrence J ^c   Vilen, Barbara J ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN G; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CONTROLLED STUDY; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; LIGAND BINDING; LUPUS VULGARIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 34548839875     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-12-061648     Document Type: Article

References (46)

1. Wang Y, Krieg AM. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int Immunol. 2003;15:223-231.
2. Leadbetter EA, Rifkin IR, Hohlbaum AM, et al. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416:603-607.
3. Lau CM, Broughton C, Tabor AS, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med. 2005;202:1171-1177.
4. Hannum LG, Ni D, Haberman AM, Weigert MG, Shlomchik MJ. A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J Exp Med. 1996;184:1269-1278.
5. Viglianti GA, Lau CM, Hanley TM, et al. Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003;19:837-847.
6. Randall TD, Heath AW, Santos-Argumedo L, et al. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers. Immunity. 1998;8:733-742.
7. Rathmell JC, Townsend SE, Xu JC, Flavell RA, Goodnow CC. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell. 1996;87:319-329.
8. Kilmon MA, Rutan JA, Clarke SH, Vilen BJ. Cutting edge: low-affinity, smith antigen-specific B cells are tolerized by dendritic cells and macrophages. J Immunol. 2005;175:37-41.
9. Borrero M, Clarke SH. Low-affinity anti-Smith antigen B cells are regulated by anergy as opposed to developmental arrest or differentiation to B-1. J Immunol. 2002;168:13-21.
10. Santulli-Marotto S, Retter MW, Gee R, Mamula MJ, Clarke SH. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity. 1998;8:209-219.
11. Benschop RJ, Aviszus K, Zhang X, et al. Activation and anergy in bone marrow B cells of a novel immunoglobulin transgenic mouse that is both hapten specific and autoreactive. Immunity. 2001;14:33-43.
12. Goodnow CC, Crosbie J, Adelstein S, et al. Altered immunoglobulin expression and functional silencing of self- reactive B lymphocytes in transgenic mice. Nature. 1988;334:676-682.
13. Phan TG, Amesbury M, Gardam S, et al. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J Exp Med. 2003;197:845-860.
14. Cho S, Conrad DH. A new multivalent B cell activation model-anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation. Int Immunol. 1997;9:239-248.
15. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. Induction of self-tolerance in mature peripheral B lymphocytes. Nature. 1989;342:385-391.
16. Inaoki M, Sato S, Weintraub BC, Goodnow CC, Tedder TF. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med. 1997;186:1923-1931.
17. Qian Y, Wang H, Clarke SH. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol. 2004;172:625-635.
18. Culton DA, O'Conner BP, Conway KL, et al. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J Immunol. 2006;176:790-802.
19. Marino JH, Cook P, Miller KS. Accurate and statistically verified quantification of relative mRNA abundances using SYBR Green I and real-time RT-PCR. J Immunol Methods. 2003;283:291-306.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
21. Retter MW, Eisenberg RA, Cohen PL, Clarke SH. Sm and DNA binding by dual reactive B cells requires distinct VH, V kappa, and VH CDR3 structures. J Immunol. 1995;155:2248-2257.
22. Fanslow WC, Srinivasan S, Paxton R, et al. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol. 1994;6:267-278.
23. Gauld SB, Benschop RJ, Merrell KT, Cambier JC. Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling. Nat Immunol. 2005;6:1160-1167.
24. Silvy A, Lagresle C, Bella C, Defrance T. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent. Eur J Immunol. 1996;26:517-524.
25. Knödel M, Kuss AW, Berberich I, Schimpl A. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching. Eur J Immunol. 2001;31:1972-1980.
26. Levine J, Hartwell D, Beller DI. Imbalanced cytokine production by macrophages from autoimmune-prone mice. Immunol Lett. 1991;30:183-192.
27. Alleva DG, Kaser SB, Beller DI. Aberrant cytokine expression and autocrine regulation characterize macrophages from young MRL+/+ and NZB/W F1 lupus-prone mice. J Immunol. 1997;159:5610-5619.
28. Gilbert MR, Carnathan DG, Cogswell PC, et al. Dendritic cells from lupus-prone mice are defective in repressing immunoglobulin secretion. J Immunol. 2007;178:4803-4810.
29. Callard RE, Herbert J, Smith SH, Armitage RJ, Costelloe KE. CD40 cross-linking inhibits specific antibody production by human B cells. Int Immunol. 1995;7:1809-1815.
30. Arpin C, Dechanet J, Van Kooten C, et al. Generation of memory B cells and plasma cells in vitro. Science. 1995;268:720-722.
31. Bergman MC, Attrep JF, Grammer AC, Lipsky PE. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively. J Immunol. 1996;156:3118-3132.
32. Axcrona K, Gray D, Leanderson T. Regulation of B cell growth and differentiation via CD21 and CD40. Eur J Immunol. 1996;26:2203-2207.
33. Lane P, Burdet C, McConnell F, Lanzavecchia A, Padovan E. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur J Immunol. 1995;25:1788-1793.
34. Gray D, Dullforce P, Jainandunsing S. Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction. J Exp Med. 1994;180:141-155.
35. Rui L, Vinuesa CG, Blasioli J, Goodnow CC. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling. Nat Immunol. 2003;4:594-600.
36. Wheeler K, Pound JD, Gordon J, Jefferis R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur J Immunol. 1993;23:1165-1168.
37. Bishop GA, Warren WD, Berton MT. Signaling via major histocompatibility complex class II molecules and antigen receptors enhances the B cell response to gp39/CD40 ligand. Eur J Immunol. 1995;25:1230-1238.
38. Liu YJ, Joshua DE, Williams GT, et al. Mechanism of antigen-driven selection in germinal centres. Nature. 1989;342:929-931.
39. Tsubata T, Wu J, Honjo T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature. 1993;364:645-648.
40. Mizuno T, Rothstein TL. Cutting edge: CD40 engagement eliminates the need for Bruton's tyrosine kinase in B cell receptor signaling for NF-kappa B. J Immunol. 2003;170:2806-2810.
41. Mizuno T, Rothstein TL. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation. J Immunol. 2005;174:3369-3376.
42. Mizuno T, Rothstein TL. B cell receptor (BCR) cross-talk: CD40 engagement creates an alternate pathway for BCR signaling that activates I kappa B kinase/I kappa B alpha/NF-kappa B without the need for PI3K and phospholipase C gamma. J Immunol. 2005;174:6062-6070.
43. Hawiger D, Inaba K, Dorsett Y, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769-779.
44. Koh JS, Wang Z, Levine JS. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J Immunol. 2000;165:4190-4201.
45. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol. 2003;170:3223-3232.
46. Herrmann M, Voll RE, Zoller OM, et al. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1241-1250.